Geneos Wealth Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-27
Closed -$542 2821
2025
Q2
$542 Buy
+27
New +$519 ﹤0.01% 3097
2022
Q3
Sell
-700
Closed -$10K 2296
2022
Q2
$10K Sell
700
-8
-1% -$131 ﹤0.01% 1944
2022
Q1
$13K Buy
708
+8
+1% +$143 ﹤0.01% 1973
2021
Q4
$12K Hold
700
﹤0.01% 2103
2021
Q3
$11K Hold
700
﹤0.01% 2184
2021
Q2
$9K Hold
700
﹤0.01% 2230
2021
Q1
$8K Hold
700
﹤0.01% 2477
2020
Q4
$8K Sell
700
-1,225
-64% -$13.2K ﹤0.01% 2304
2020
Q3
$20K Hold
1,925
﹤0.01% 1654
2020
Q2
$26K Hold
1,925
﹤0.01% 1505
2020
Q1
$21K Hold
1,925
﹤0.01% 1489
2019
Q4
$27K Hold
1,925
﹤0.01% 1558
2019
Q3
$19K Sell
1,925
-850
-31% -$10.2K ﹤0.01% 1630
2019
Q2
$40K Hold
2,775
﹤0.01% 1304
2019
Q1
$38K Hold
2,775
﹤0.01% 1274
2018
Q4
$47K Sell
2,775
-350
-11% -$5.68K ﹤0.01% 1128
2018
Q3
$47K Hold
3,125
﹤0.01% 1194
2018
Q2
$43K Hold
3,125
﹤0.01% 1116
2018
Q1
$52K Hold
3,125
﹤0.01% 976
2017
Q4
$44K Hold
3,125
﹤0.01% 1060
2017
Q3
$44K Hold
3,125
﹤0.01% 1008
2017
Q2
$40K Hold
3,125
﹤0.01% 1016
2017
Q1
$43K Sell
3,125
-71
-2% -$836 ﹤0.01% 942
2016
Q4
$34K Sell
3,196
-1,350
-30% -$14.2K ﹤0.01% 977
2016
Q3
$49K Sell
4,546
-679
-13% -$7.92K 0.01% 818
2016
Q2
$57K Hold
5,225
0.01% 762
2016
Q1
$67K Buy
+5,225
New +$57.3K 0.01% 699

Other funds holding INVA

Geneos Wealth Management's INVA Position: Q3 2025 in Review

Geneos Wealth Management sold out of Innoviva (INVA) in Q3 2025, closing a stake of 27 shares — an estimated $542 sold.

Geneos Wealth Management first reported a position in INVA in Q1 2016 and held it in 27 quarters. The position peaked at $67K in Q1 2016. 264 funds tracked by Wall St. Rank hold INVA as of Q3 2025.

  • Geneos Wealth Management reported no remaining Innoviva position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 27 Innoviva shares in Q3 2025, an estimated $542.
  • Geneos Wealth Management first reported a position in Innoviva in Q1 2016 and held it in 27 quarters.
  • Geneos Wealth Management's Innoviva position peaked at $67K in Q1 2016.
  • 264 funds tracked by Wall St. Rank held Innoviva as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.